Back

Multiple vascular endothelial growth factor (-receptor) polymorphisms modify the treatment benefit of ACE-inhibitors on cardiovascular outcome

19 April 2018 (11:45 - 11:56)
Organised by:
Congress Presentation Part of: Rapid Fire Session I Pharmacology and Pharmacotherapy, Other EAPC Premium Access EuroPrevent 2018

About the speaker

Photo
Ms Nermina Buljubasic

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Cost-effectiveness of guideline adherence in coronary patients: results from the EUROASPIRE IV survey - a registry from the european society of cardiology
Doctor D. De Smedt (Ghent, BE)
Abstract Slides Video
Presentation thumbnail
LDL extracellular vesicle coagulation protein levels change after initiation of statin therapy in patients with subclinical atherosclerosis. Findings from the METEOR trial
Ms L. Willemsen (Utrecht, NL)
Abstract
Presentation thumbnail
Relationship between the shift of socioeconomic status and cardiovascular mortality
Doctor J. Sung (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Excess mortality of non-participants indicates that low participation rates in health examination surveys bias population level risk factor estimates
Doctor H. Tolonen (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Endothelial microparticles-mediated transfer of microRNA-19b promotes atherosclerosis via targeting RNF-11

Access the full session

Session thumbnail
Rapid Fire Session I

The Event

Event poster

EuroPrevent 2018

19 April 2018 11:45 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources